If you suffer from Obsessive-Compulsive Disorder (OCD) and have had symptoms and/or a diagnosis for more than a year, you are invited to join a new OCD clinical trial!

The researchers are studying an investigational drug Troriluzole (BHV-4157) as a possible treatment for OCD.

If you are between the ages of 18 and 65 years old and suffer from the symptoms of OCD, you may qualify.

All eligible participants can be paid up to £490.

Please contact or call 01793 327954 for more information.

Participant Information Sheet

Letter of Ethical Approval